• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

Prevalence of type II diabetes on the rise since 1980s

byJohn PrendergassandPriyanka Vedak
September 10, 2015
in Cardiology, Public Health
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. In this study, a significant increase in the prevalence of diabetes was noted across every gender, age group, racial/ethnic group, education level, and income level.

2. This study found that when adjusted for age, diabetes was more common among non-Hispanic black, non-Hispanic Asian, and Hispanic individuals than it was among non-Hispanic white individuals.

Evidence Rating Level: 2 (Good)

Study Rundown: Type II diabetes is a chronic condition that affects the way our bodies metabolize glucose. Genetic and environmental factors such as weight and physical inactivity both contribute to one’s predisposition. Excess glucose results in the numerous complications of diabetes including neuropathies, retinopathy, and heart disease. This study aimed to estimate the prevalence and update the national trends of diabetes in US adults. In order to do so, the authors of this study analyzed data from the National Health and Nutrition Examination Survey (NHANES) and compared data from various cohorts from 1988 to 2012.

This study noted a significant increase in the prevalence of diabetes across every gender, age group, racial/ethnic group, education level, and income level when comparing data from 1988-1994 with that from 2011-2012. The study is strengthened by its use of NHANES data, which measures a large sample population with a strict study protocol. Limitations were due to the self-reported nature of measuring previous diabetes as well as possible diabetes misclassification in some groups. While measures to increase physical activity, control children’s diets, and increase health insurance coverage have been making headway, these findings demonstrate that continued efforts will be required for the country to manage this condition.

Click to read the study in JAMA (Journal of the American Medical Association)

RELATED REPORTS

In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks

Historical redlining associated with lower breast cancer screening across urban neighborhoods

Click to read the accompanying editorial in JAMA

Relevant Reading: Prevalence and Incidence Trends for Diagnosed Diabetes Among Adults Aged 20 to 79 Years, United States, 1980-2012

FDA approvedFor type 2 diabetes: Onswik (insulin efsitora alfa-gobe), Sep 23, 2026→

In-Depth [cross-sectional study]: This study evaluated data collected in the 1988-1994 and the 1999-2000 to 2011-2012 NHANES. Data from 23 634 adults between 1988-2010 was used to measure trends and from 2,781 adults between 2011-2012 to measure prevalence. Compared with non-Hispanic white participants (11.3%; 95%CI 9.0%-14.1%), the age-standardized prevalence of diabetes in the 2011-2012 group was higher in non-Hispanic black participants (21.8%; 95%CI 17.7%-26.7%]; p < 0.001), non-Hispanic Asian participants (20.6%; 95%CI 15.0%-27.6%; p = 0.007), and Hispanic participants (22.6%; 95%CI 18.4%-27.5%; p < 0.001). A significant increase in the prevalence of diabetes was noted across every gender, age group, racial/ethnic group, education level, and income level, with an overall increase in prevalence from 9.8% (95%CI 8.9-10.6) in 1988-1994 to 12.4% (95%CI 10.8-14.2) with a p 0<0.001.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: prevalencetype 2 diabetes
Previous Post

Psychiatric disorders linked with increased risk of violent re-offense in released prisoners

Next Post

Enzyme replacement therapy shows promise for rare lysosomal storage disease: The ARISE study

RelatedReports

A balance scale with a syringe on one side and silhouettes of varying body sizes on the other, symbolizing weight management and GLP-1 medications.
2MM Trial Briefs

In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks

October 29, 2026
A middle-aged woman looks thoughtfully at an abstract representation of cells and a statin pill, symbolizing breast cancer and medication usage.
Oncology

Historical redlining associated with lower breast cancer screening across urban neighborhoods

September 13, 2026
A balance scale featuring a plate, an hourglass, and stacked papers, symbolizing nutrition, time management, and evidence-based practices.
Chronic Disease

Higher coffee intake is associated with lower visceral fat despite similar body mass index

September 8, 2026
Physical activity collage: a smiling middle-aged man in a track jacket beside a city bicycle and a teal resistance band
Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026
Next Post

Enzyme replacement therapy shows promise for rare lysosomal storage disease: The ARISE study

Targeted autologous transfusion may aid advanced refractory multiple myeloma

Targeted autologous transfusion may aid advanced refractory multiple myeloma

Pre-exposure prophylaxis (PrEP) effective in preventing HIV infection in high-risk gay men

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Continuation of immunotherapy after immune checkpoint inhibitor-induced myocarditis in patients with lung cancer may be safe and effective
  • Venglustat is approved for neurological symptoms of type 3 Gaucher disease in patients weighing at least 15 kg
  • Medicaid-reimbursed weight-loss GLP-1 prescriptions fell after coverage withdrawal in 4 states
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.